HealthEquity, Inc. (HQY)

NMS – Real vaqt narxi. Valyuta: USD

80.46

-1.19 (-1.46%)

Yopilishda: May 12, 2026, 4:00 PM EDT

06.05.2026

HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

05.05.2026

HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule

DRAPER, Utah, May 05, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced plans to release financial results for its first quarter of fiscal 2027, after the close of regular stock market trading on Thursday, May 28, 2026. Following the news release, HealthEquity management will host a conference call for investors on Thursday, May 28, 2026, at 4:30 p.m.

29.04.2026

SOLV vs. HQY: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?

28.04.2026

HealthEquity (HQY) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

16.04.2026

Why Is HealthEquity (HQY) Up 5.2% Since Last Earnings Report?

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock?

16.04.2026

Here's Why HealthEquity (HQY) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

16.04.2026

HealthEquity: This Financial Powerhouse Is Poised To Compound Wealth (Upgrade)

HealthEquity is upgraded from 'Hold' to 'Buy,' reflecting visible operating leverage and durable growth drivers. HQY's fiscal Q4 2026 saw 7% revenue growth, 500+ bps margin expansion, and 23% adjusted EBITDA growth, signaling an earnings inflection. Structural tailwinds include expanded HSA eligibility, rising engagement, and a shift toward higher-value, compounding accounts.

Videolar

12.11.2025

Neutral

Final Trades: Taiwan Semi, HealthEquity, CBOE Global Markets and the XBI

Press-relizlar

30.03.2026

HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors

DRAPER, Utah, March 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced that William ‘Bill' Gassen, president and chief executive officer of Sanford Health, has been elected to its board of directors (the “Board”) effective March 26, 2026. He will also serve on the Audit and Risk Committee and Talent, Compensation and Culture Committee of the Board. His appointment expands the Board to 10 directors, eight of whom are independent.

17.03.2026

HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

Highlights of the fiscal year include: Revenue increased 9% to $1.31 billion. Net income increased 123% to $215.2 million, and net income margin increased to 16% from 8% last year.

17.02.2026

HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

DRAPER, Utah, Feb. 17, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA”) custodian by number of accounts and leading provider of complementary consumer-directed benefits (“CDBs”), today announced its HSAs, HSA Assets, and Total Accounts as of its fiscal year ended January 31, 2026. The Company also reaffirmed its guidance for fiscal 2026 and 2027, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations.

03.12.2025

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

Highlights of the third quarter include: Revenue increased 7% to $322.2 million. Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased 29% to $1.01.

HealthEquity, Inc. (HQY)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

HealthEquity, Inc. (HQY)

HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?

HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule

SOLV vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) is a Top-Ranked Momentum Stock: Should You Buy?

Why Is HealthEquity (HQY) Up 5.2% Since Last Earnings Report?

Here's Why HealthEquity (HQY) is a Strong Growth Stock

HealthEquity: This Financial Powerhouse Is Poised To Compound Wealth (Upgrade)

Videolar

Press-relizlar

HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors

HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?

HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule

SOLV vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) is a Top-Ranked Momentum Stock: Should You Buy?

Why Is HealthEquity (HQY) Up 5.2% Since Last Earnings Report?

Here's Why HealthEquity (HQY) is a Strong Growth Stock

HealthEquity: This Financial Powerhouse Is Poised To Compound Wealth (Upgrade)

Videolar

Press-relizlar

HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors

HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

Search stocks

HealthEquity, Inc. (HQY)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

HealthEquity, Inc. (HQY)

HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?

HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule

SOLV vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) is a Top-Ranked Momentum Stock: Should You Buy?

Why Is HealthEquity (HQY) Up 5.2% Since Last Earnings Report?

Here's Why HealthEquity (HQY) is a Strong Growth Stock

HealthEquity: This Financial Powerhouse Is Poised To Compound Wealth (Upgrade)

Videolar

Press-relizlar

HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors

HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?

HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule

SOLV vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) is a Top-Ranked Momentum Stock: Should You Buy?

Why Is HealthEquity (HQY) Up 5.2% Since Last Earnings Report?

Here's Why HealthEquity (HQY) is a Strong Growth Stock

HealthEquity: This Financial Powerhouse Is Poised To Compound Wealth (Upgrade)

Videolar

Press-relizlar

HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors

HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results